With over 250 investigators, the II-ON has undertaken more than 150 research projects across 20 tumor types including 12 clinical trials since its launch in 2012
Global collaboration now includes 15 leading academic institutions
Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre | BMS Newsroom
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.